🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In Atrial Functional MR can get “Hamstringing”of posterior MV leaflet due to massive LA dilation;this “atriogenic” leaflet tethering is from displaced posterior annulus onto crest of LV inlet resulting in⬆️in annulopapillary distance restricting leaflet motion #echofirst

💉 GLP-1 meds don’t just curb appetite—sometimes they curb essential nutrients too. - - - 📉 In a study of 460,000+ adults on GLP-1s (mostly with T2D): 🔹13% developed nutritional deficiencies in 6 months 🔹22% within 12 months 🔹Vitamin D deficiency was most common (13.6%) 🔹3%

Hypertrophic cardiomyopathy carries some risk of sudden death but it is hard to predict who is at high-risk for an implantable cardioverter-defibrillator (ICD). Enter multimodal A.I. nature.com/articles/s4416…

a possible gamechanger: a multimodal AI model based on LGE-CMR, EHR, & clinical data predicts sudden cardiac death in hypertrophic cardiomyopathy with AUROC of 0.81, beating ACC/AHA (0.51) & ESC (0.54) guidelines and risk calculators #Cardiology #AI doi.org/10.1038/s44161…

New American Society of Echocardiography Diastology guidelines now published (tinyurl.com/2698zcsk). New algorithm below, now with LARS and IVRT. Also new recs for OHT, MAC, and AF patients. Congrats Sherif F Nagueh Danita Sanborn and coauthors Jae K. Oh Bonita Anderson Kristen Billick Allan L. Klein et al.

Still hearing a lot about “Blue Zones” being the secret to longevity. But the theory was debunked a while ago. Areas of the world with people claiming to be 110+ years old are actually just places with poor record keeping and a lot of pension fraud. When official birth

It’s a truly curious observation. Most curious is that some of the atrial structural changes in endurance exercisers is similar to the changes seen in obesity.

Artificial Intelligence for Cardiovascular Care: Advances: JACC Review AI models can detect cardiovascular disorders including reduced ejection fraction, valvular heart disease, and cardiomyopathies from electrocardiograms with accuracy not previously achieved by human experts

“If you treat someone’s blood pressure or cholesterol you don’t get improvements in quality of life. You treat their weight you get all the benefits." "That is the power of treating obesity.” Inspiring talk by Dr. Lou Aronne on the clinical implications of CagriSema at

🚨 New in Heart Rhythm: This is BIG ICD battery longevity varies by 2–3 years depending on manufacturer and number of leads. 🔋 Newer devices last 2–4 years longer. 📉 Each additional lead = 2–3 yrs less battery life. 📈 Key drivers: manufacturer, pulse width, output. We need

Dobutamine Stress Echocardiography for Valvular assessment

🔴Anticoagulation in Patients with CKD⤵️ #2024Review #OpenAccess 🔹Dosing recommendations for DOACs in patients with CKD. 🔹pmc.ncbi.nlm.nih.gov/articles/PMC10… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros

Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity Treatment with tirzepatide led to a lower risk of a composite of death from cardiovascular causes or worsening heart failure than placebo and improved health status in patients with heart failure with

Absolutely thrilled about the recent regulatory clearances of our cardiac amyloidosis (CA) detection model. This is a game-changer in early CA diagnosis—bringing speed, accuracy, and scale to a condition that’s too often missed or delayed. Proud of the impact this will have!

New in #JACCHF JACC Journals, direct to physician communication by industry led to increased uptake of ARNI and SGLT2i but not BB, ACE/ARB or MRA. What happens when SGLT2i and ARNI are generic? All #GDMT saves lives! #GDMTworks jacc.org/doi/10.1016/j.…

This AI screening model used only an apical 4ch echo videoclip & effectively differentiated cardiac amyloidosis from other causes of ⬆️ wall thickness

🚨New Publication Alert: Our Landmark Study Published in the European Heart Journal! We’re proud to share that our latest study demonstrates that EchoGo® Amyloidosis, Ultromics’ FDA-cleared AI tool, significantly improves the detection of cardiac amyloidosis using a single

Bonus: What RV walls and Tricuspid leaflets are seen in the RV inflow view? 👇 #POCUS #FOAMed Also keep in mind that Doppler alignment with the TR jet may not be optimal in this view. Whenever possible, obtain measurements from multiple views.

$TSLA TO LAUNCH ROBOTAXI SERVICE IN BAY AREA WITHIN TWO MONTHS